mycobacterium tuberculosis reference strain h37rv (ATCC)
ATCC is a verified supplier 
ATCC manufactures this product 
98
Structured Review
ATCC
mycobacterium tuberculosis reference strain h37rv
Mycobacterium Tuberculosis Reference Strain H37rv, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 2908 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/h37rv+reference+strain/Mycobacterium+tuberculosis%3B+subsp%2E+tuberculosis/pm41679834-42-1-6
Average 98 stars, based on 2908 article reviews
Mycobacterium Tuberculosis Reference Strain H37rv, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 2908 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/h37rv+reference+strain/Mycobacterium+tuberculosis%3B+subsp%2E+tuberculosis/pm41679834-42-1-6
Average 98 stars, based on 2908 article reviews
mycobacterium tuberculosis reference strain h37rv - by Bioz Stars,
2026-10
98/100 stars
Images
Related Articles
Mutagenesis:Article Title: Highly Sensitive Detection of Complicated Mutations of Drug Resistance in Mycobacterium tuberculosis Using a Simple, Accurate, Rapid, and Low-Cost Tailored-Design Competitive Wild-Type Blocking Assay. Article Snippet: Drug-resistant Mycobacterium tuberculosis continues to be a global public health threat despite the development of new diagnostics and antitubercular drugs.. [1] Shockingly, the World Health Organization (WHO) has estimated that for more than 10 years, the proportion of people diagnosed with tuberculosis (TB) for the first time who had multidrug-resistant (MDR)/rifampin-resistant (RR)-TB has remained unexpectedly as high as about 3%–4% and for those previously treated for TB has remained about 18%–21%.. [2] Hence, identifying patients with drugresistant TB as rapidly and accurately as possible is crucial for effective treatment and appropriate infection control. Article Title: Highly Sensitive Detection of Isoniazid Heteroresistance in Mycobacterium tuberculosis by DeepMelt Assay Article Snippet: The remaining 1.5-mL proportion of the decontaminated 232 on N ovem ber 10, 2017 by G A Z I U N IV E R S IT E S I http://jcm .asm .org/ D ow nloaded from 13 specimens was subjected to DNA extraction using Lab-Aid 824 MTB DNA Extraction 233 Kit (Zeesan Biotech, Xiamen, China). .. 234 Wild-type MTB genomic DNA (gDNA) and mutant MTB gDNA were purified from 235 an Purification:Article Title: Highly Sensitive Detection of Isoniazid Heteroresistance in Mycobacterium tuberculosis by DeepMelt Assay Article Snippet: The remaining 1.5-mL proportion of the decontaminated 232 on N ovem ber 10, 2017 by G A Z I U N IV E R S IT E S I http://jcm .asm .org/ D ow nloaded from 13 specimens was subjected to DNA extraction using Lab-Aid 824 MTB DNA Extraction 233 Kit (Zeesan Biotech, Xiamen, China). .. 234 Wild-type MTB genomic DNA (gDNA) and mutant MTB gDNA were purified from 235 an Spectrophotometry:Article Title: Highly Sensitive Detection of Isoniazid Heteroresistance in Mycobacterium tuberculosis by DeepMelt Assay Article Snippet: The remaining 1.5-mL proportion of the decontaminated 232 on N ovem ber 10, 2017 by G A Z I U N IV E R S IT E S I http://jcm .asm .org/ D ow nloaded from 13 specimens was subjected to DNA extraction using Lab-Aid 824 MTB DNA Extraction 233 Kit (Zeesan Biotech, Xiamen, China). .. 234 Wild-type MTB genomic DNA (gDNA) and mutant MTB gDNA were purified from 235 an Control:Article Title: Epidemiology of drug-resistant tuberculosis among hospitalized children with tuberculosis in southwest China, 2017–2024 Article Snippet: Phenotypic DST was performed using the MicroDSTTM system (Yinke AUTOBIO Diagnostics Co., Ltd., Zhuhai, China), testing susceptibility to 14 antituberculosis drugs: first-line drugs including isoniazid (0.2–1.6 μg/mL), rifampicin (1–8 μg/mL), ethambutol (2.5–20 μg/mL), and streptomycin (1–8 μg/mL); and second-line drugs including rifapentine (0.5–2 μg/mL), levofloxacin (2–8 μg/mL), amikacin (1–4 μg/mL), capreomycin (2.5–10 μg/mL), protionamide (10–40 μg/mL), pasiniazide (0.5–2 μg/mL), moxifloxacin (0.5–2 μg/mL), p-aminosalicylic acid (2–8 μg/mL), clarithromycin (4–16 μg/mL), rifabutin (0.75–3 μg/mL), kanamycin (2.5–10 μg/mL), and clofazimine (2–8 μg/mL). .. Quality control was maintained using the other:Article Title: Bedaquiline and clofazimine resistance in Mycobacterium tuberculosis: an in-vitro and in-silico data analysis Article Snippet: In-vitro evolution experiments were done with the |
